Oxysterol signalling is retained in ER-negative and supressed in ER-positive breast cancer

被引:0
|
作者
Hutchinson, Samantha [1 ]
Battaglia, Sebastiano [2 ]
Roberg-Larsen, Hanne [3 ]
Lianto, Priscilia [1 ]
Hughes, Thomas [1 ]
Thorne, James [1 ]
机构
[1] Univ Leeds, Leeds, W Yorkshire, England
[2] Roswell Park Inst, Buffalo, NY USA
[3] Univ Oslo, Oslo, Norway
关键词
D O I
10.1017/S0029665120000907
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
引用
收藏
页码:E142 / E142
页数:1
相关论文
共 50 条
  • [21] ANALYSIS OF THE ESTROGEN-RECEPTOR (ER) GENE, TRANSCRIPT AND PROTEIN IN ER-POSITIVE AND ER-NEGATIVE BREAST-CANCER CELL-LINES
    YAICH, LE
    ROODI, N
    BAILEY, LR
    VERRIER, CS
    YEE, CJ
    CAVENER, DR
    PARL, FF
    [J]. ENDOCRINE-RELATED CANCER, 1995, 2 (04) : 293 - 309
  • [22] Rapid Activation of cPLA2α Induced by Estrogen in ER-Positive and ER-Negative Breast Cancer Cell Lines.
    Caiazza, F.
    Thomas, W.
    Harvey, B. J.
    [J]. ENDOCRINE REVIEWS, 2010, 31 (03)
  • [23] INFLUENCE OF HORMONES ON PROLIFERATION OF ER-POSITIVE CELLS AND ER-NEGATIVE CELLS OF HUMAN-BREAST CANCER (MCF-7)
    NOGUCHI, M
    TAJIRI, K
    TANIYA, T
    KUMAKI, T
    ASHIKARI, A
    MIYAZAKI, I
    [J]. ONCOLOGY, 1990, 47 (01) : 19 - 24
  • [24] Effects of vitamin Don obesity induced increase in ER-positive and ER-negative mammary cancer in mice
    Yu, Wei
    Kim, Dominic
    Sumis, Allison
    Hilakivi-clarke, Leana
    [J]. CANCER RESEARCH, 2011, 71
  • [25] Sex Hormones and Risk of Estrogen Receptor (ER)-Positive and ER-Negative Breast Cancer
    Farhat, G. N.
    Cummings, S. R.
    Parimi, N.
    Huang, A.
    Cauley, J. A.
    Rohan, T. E.
    Hubbell, F. A.
    Vitolins, M.
    Manson, J. E.
    Chlebowski, R. T.
    Lee, J.
    [J]. CANCER RESEARCH, 2009, 69 (24) : 533S - 533S
  • [26] Prevention of ER-negative breast cancer
    Brown, P. H.
    [J]. EJC SUPPLEMENTS, 2008, 6 (03): : 22 - 22
  • [27] Prevention of ER-Negative Breast Cancer
    Li, Yuxin
    Brown, Powel H.
    [J]. CANCER PREVENTION II, 2009, 181 : 121 - 134
  • [28] ER-Negative Breast Cancer Is Highly Responsive to Cholesterol Metabolite Signalling
    Hutchinson, Samantha A.
    Lianto, Priscilia
    Roberg-Larsen, Hanne
    Battaglia, Sebastiano
    Hughes, Thomas A.
    Thorne, James L.
    [J]. NUTRIENTS, 2019, 11 (11)
  • [29] Chemotherapy (CT) for isolated locoregional recurrence (ILRR) of breast cancer in ER-positive (ER plus ) and ER-negative (ER-) cohorts: Final analysis of the CALOR trial
    Wapnir, Irene
    Price, Karen N.
    Anderson, Stewart J.
    Robidoux, Andre
    Nortier, Miguel Martin J. W. R.
    Paterson, Alexander H. G.
    Rimawi, Mothaffar F.
    Lang, Istvan
    Canada, Jose Manuel Baena
    Thurlimann, Beat J. K.
    Mamounas, Eleftherios P.
    Geyer, Charles E.
    Gelber, Shari I.
    Coates, Alan S.
    Gelber, Richard D.
    Rastogi, Priya
    Regan, Meredith M.
    Wolmark, Norman
    Aebi, Stefan Paul
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [30] MIR-190B-5P EXPRESSION IS A HIGHLY RELIABLE DISCRIMINATOR BETWEEN ER-POSITIVE AND ER-NEGATIVE BREAST CANCER
    Iyevleva, A.
    Bizin, I.
    Sokolenko, A.
    Venina, A.
    Anisimova, E.
    Holmatov, M.
    Romanko, A.
    Stepanov, I.
    Togo, A.
    Imyanitov, E.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A181 - A181